Mathematical model of chimeric anti-gene receptor (CAR) T cell therapy with presence of cytokine

In this paper, we reconstruct a mathematical model of therapy by CAR T cells for acute lymphoblastic leukemia (ALL) With injection of modified T cells to body, then some signs such as fever, nausea and etc appear. These signs occur for the sake of cytokine release syndrome (CRS). This syndrome has a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Mostolizadeh, Reihaneh (VerfasserIn) , Afsharnezhad, Zahra (VerfasserIn) , Marciniak-Czochra, Anna (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: 2018
In: Numerical algebra, control and optimization
Year: 2018, Jahrgang: 8, Heft: 1, Pages: 63-80
ISSN:2155-3297
DOI:10.3934/naco.2018004
Online-Zugang:Resolving-System, Volltext: http://dx.doi.org/10.3934/naco.2018004
Volltext
Verfasserangaben:Reihaneh Mostolizadeh, Zahra Afsharnezhad, Anna Marciniak-Czochra
Beschreibung
Zusammenfassung:In this paper, we reconstruct a mathematical model of therapy by CAR T cells for acute lymphoblastic leukemia (ALL) With injection of modified T cells to body, then some signs such as fever, nausea and etc appear. These signs occur for the sake of cytokine release syndrome (CRS). This syndrome has a direct effect on result and satisfaction of therapy. So, the presence of cytokine will be played an important role in modelling process of therapy (CAR T cells). Therefore, the model will include the CAR T cells, B healthy and cancer cells, other circulating lymphocytes in blood, and cytokine. We analyse stability conditions of therapy Without any control, the dynamic model evidences sub-clinical or clinical decay, chronic destabilization, singularity immediately after a few hours and finally, it depends on the initial conditions. Hence, we try to show by which conditions, therapy will be effective. For this aim, we apply optimal control theory.
Beschreibung:Gesehen am 27.06.0218
Beschreibung:Online Resource
ISSN:2155-3297
DOI:10.3934/naco.2018004